Highlights,Institutional investors have adjusted their stakes in Inari Medical, contributing to market engagement.,The ...

The wearable cardiac monitor and defibrillator developer Kestra Medical Technologies aims to raise about $154 million by ...

We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going ...

花旗更新后的财务模型考虑了Inari对Stryker业绩的预期贡献。预计Inari在2025年约10个月期间将产生5.9亿美元的收入。尽管预计Inari将使Stryker的营业利润率降低0-20基点，但预计也将为每股收益（EPS）增加0.20至0.30美元。

Citi resumed coverage of Stryker (SYK) with a Buy rating and $450 price target following the close of the Inari acquisition tryker has built a ...

William Blair analyst Margaret Kaczor maintained a Buy rating on Inogen (INGN – Research Report) today. The company’s shares closed yesterday ...